Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension

Diabetes and Vascular Disease Research

Volumn 8, Issue 1, 2011, Pages 43-46

  Knobler, Hilla ^a   Abbasi, Fahim ^b   Lamendola, Cindy ^b   Reaven, Gerald M ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CVD risk factors; insulin resistance; prehypertension

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OCTREOTIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREHYPERTENSION; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; PREHYPERTENSION; RISK FACTORS;

EID: 79251633446     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.1177/1479164110396919     Document Type: Article

References (20)

1. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001 ; 345: 1291-1297.
2. Lewington S., Clarke R., Qizilbash N., Peto R. and Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 ; 360: 1903-1913.
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 ; 42: 1206-1252.
4. Gaziano JM, Sesso HD, Breslow JL, Hennekens CH and Buring JE Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. Am J Cardiol 1999 ; 84: 768-773.
5. Jeppesen J., Hein HO, Suadicani P. and Gyntelberg F. Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 2001 ; 161: 361-366.
6. Reaven GM Role of insulin resistance in human disease. Diabetes 1988 ; 37: 1595-1607.
7. Greenlund KJ, Croft JB and Mensah GA Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004 ; 164: 2113-2118.
8. Kanauchi M., Kanauchi K., Inoue T., Kimura K. and Saito Y. Surrogate markers of insulin resistance in assessing individuals with new categories 'prehypertension' and 'prediabetes'. Clin Chem Lab Med 2007 ; 45: 35-39.
9. Player MS, Mainous AG 3rd, Diaz VA and Everett CJ Prehypertension and insulin resistance in a nationally representative adult population. J Clin Hypertension 2007 ; 9: 424-429.
10. Hwu CM, Liou TL, Hsiao LC and Lin MW Prehypertension is associated with insulin resistance. QJM 2009 ; 102: 705-711.
11. Cordero A., Laclaustra M., Leon M., et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A metabolic syndrome in active subjects in Spain. Am J Hypertens 2006 ; 19: 189-196.
12. Williams RR, Rao DC, Ellison RC, et al. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. Ann Epidemiol 2000 ; 10: 389-400.
13. Pei D., Jones CN, Bhargava R., Chen YD and Reaven GM Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994 ; 37: 843-845.
14. Shen SW, Reaven GM and Farquhar JW Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970 ; 49: 2151-2160.
15. Greenfield MS, Doberne L., Kraemer F., Tobey T. and Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1991 ; 30: 387-392.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 ; 285: 2486-2497.
17. Facchini FS, Hua N., Abbasi F. and Reaven GM Insulin resistance as a predictor of age- related diseases. J Clin Endocrinol Metab 2001 ; 86: 3574-3578.
18. Yeni-Komshian H., Carantoni M., Abbasi F. and Reaven GM Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 2000 ; 23: 171-175.
19. McLaughlin T., Abbasi F., Lamendola C. and Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes in obese individuals: Effect of differences in insulin sensitivity. Arch Int Med 2007 ; 167: 642-648.
20. Reaven GM Insulin resistance, hypertension, and coronary disease. J Clin Hypertens 2003 ; 5: 269-274.